Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial
Stefan Dietzsch(Leipzig University), Rolf‐Dieter Kortmann(University of Turin), Martin Benesch(St Nicholas Hospital), Christiane Matuschek(Düsseldorf University Hospital), Clemens Seidel(Leipzig University), Ralf Kitzing(Leipzig University), Julia Remmele(Leipzig University), Annett Braesigk(Leipzig University), Montserrat Pazos(LMU Klinikum), Dirk Geismar, Beate Timmermann(Essen University Hospital), Kristin Gurtner(University Hospital Carl Gustav Carus), Silke Frick(Klinikum Bremen-Mitte), Victor Lewitzki(Universitätsklinikum Würzburg), Martin Mynarek(Universität Hamburg), Karolina Jabłońska, Tina Schlender(Leipzig University), Rudolf Schwarz(Universität Hamburg), Albrecht Gluek, Marc Walser, Semi Ben Harrabi, Karin Dieckmann(University of Vienna), Nicolas U. Gerber, Stefan Rutkowski(Universität Hamburg)
Kölner Universitäts PublikationsServer (Universität zu Köln)
January 1, 2021
Cited by 1
Related Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
|Journal of Clinical Oncology|2005|654
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
|Acta Neuropathologica|2016|650
A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results
|Journal of Clinical Oncology|2012|645